Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clazosentan for prevention of cerebral vasospasm after aSAH (CONSCIOUS-1)
NCT00111085Phase 2Completed
- Sponsor
- Idorsia
- Start
- Jan 2005
- Primary completion
- Mar 2006
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial of clazosentan in aneurysmal subarachnoid hemorrhage (SAH), sponsored by Idorsia. Started Jan 2005; status: completed.
02
Drugs
clazosentan
03
Conditions
aneurysmal subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on NCT00111085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00111085.